Polymorphism of the thymidylate synthase gene and thymidylate synthase levels in colon cancer cell lines and different tissues of colorectal cancer patients

Nucleosides, Nucleotides and Nucleic Acids

Volumn 23, Issue 8-9, 2004, Pages 1381-1384

  Mauritz, R ^a   Beumer, I J ^a   Marsh, S ^b   McLeod, H L ^b   Smid, K ^a   Van Groeningen, C J ^a   Pinedo, H M ^a   Peters, G J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 Fluorouracil; Colorectal carcinoma; Polymorphism; Thymidylate synthase

Indexed keywords

MESSENGER RNA; THYMIDYLATE SYNTHASE;

AMINO ACID SEQUENCE; CANCER CELL CULTURE; CANCER RESISTANCE; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONFERENCE PAPER; ENHANCER REGION; ENZYME POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; SEQUENCE HOMOLOGY;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENOTYPE; HETEROZYGOTE; HUMANS; POLYMORPHISM, GENETIC; RNA, MESSENGER; THYMIDYLATE SYNTHASE; TISSUE DISTRIBUTION;

EID: 10344250989     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-200027634     Document Type: Conference Paper

References (10)

1. Hone, N.; Aiba, H.; Oguro, K.; Hojo, H.; Takeishi, K. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct. Funct. 1995, 20, 191-197.
2. Kawakami, K.; Salonga, D.; Park, J.M.; Danenberg, K.D.; Uetake, H.; Brabender, J.; Omura, K.; Watanabe, G.; Danenberg, P.V. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression. Clin. Cancer Res. 2001, 7, 4096-4101.
3. Villafranca, E.; Okruzhnov, Y.; Dominguez, M.A.; Garcia-Foncillas, J.; Azinovic, L; Martinez, E.; Illarramendi, J.J.; Arias, F.; Martinez, M.R.; Salgado, E.; Angeletti, S.; Brugarolas, A. Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer. J. Clin. Oncol. 2001, 19, 1779-1786.
4. Pullarkat, S.T.; Stoehlmacher, J.; Ghaderi, V.; Xiong, Y.P.; Ingles, S.A.; Sherrod, A.; Warren, R.; Tsao-Wei, D.; Groshen, S.; Lenz, H.J. Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy. Pharmacogenomics J. 2001, 1, 65-70.
5. Park, D.J.; Stoehlmacher, J.; Zhang, W.; Tsao-Wei, D.; Groshen, S.; Lenz, H.J. Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer. Int. J. Colorectal Dis. 2002, 17, 46-49.
6. Marsh, S.; Collie-Duguid, E.S.; Li, T.; Liu, X.; McLeod, H.L. Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations. Genomics 1999, 58, 310-312.
7. Van Triest, B.; Pinedo, H.M.; Van Hensbergen, Y.; Smid, K.; Telleman, F.; Schoenmakers, P.S.; Van der Wilt, C.L.; Van Laar, J.A.; Noordhuis, P.; Jansen, G.; Peters, G.J. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. Clin. Cancer Res. 1999, 5, 643-654.
8. Rots, M.G.; Willey, J.C.; Jansen, G.; Van Zantwijk, C.H.; Noordhuis, P.; DeMuth, J.P.; Kuiper, E.; Veerman, A.J.; Pieters, R.; Peters, G.J. mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method. Leukemia 2000, 14, 2166-2175.
9. Sigmond, J.; Backus, H.H.J.; Wouters, D.; Temmink, O.H.; Jansen, G.; Peters, G.J. Induction of resistance to the multitargeted antifolate Pemetrexed (ALIMTA) in WiDr human colon cancer cells is associated with thymidylate synthase overexpression. Biochem. Pharmacol. 2003, 66, 431-438.
10. Marsh, S.; McKay, J.A.; Cassidy, J.; McLeod, H.L. Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer. Int. J. Oncol. 2001, 19, 383-386.